LISAMARIE SIMMONS: Open Payments
NPI 1285179531 · FORT PIERCE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,213 in 19 payments from 11 companies in 2025. Trend: 2023 $857 · 2024 $614 · 2025 $2,213
Food & beverage: $2,213
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $489 |
| Madrigal Pharmaceuticals | 4 | $434 |
| Phathom Pharmaceuticals, Inc. | 2 | $240 |
| Ipsen Biopharmaceuticals, Inc | 1 | $150 |
| Janssen Biotech, Inc. | 1 | $150 |
| Mallinckrodt Hospital Products Inc. | 1 | $142 |
| Ardelyx, Inc. | 1 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $123 |
| Gilead Sciences, Inc. | 1 | $119 |
Products named: REZDIFFRA, RINVOQ, VOQUEZNA, IQIRVO, TREMFYA, TERLIVAZ, IBSRELA, ZENPEP.
Industry payments across FL — which companies pay providers there.
